An Open-label, Multi-center, Single-arm, Phase IV Clinical Trial Assessing Conversion From Hydrocodone, Oxycodone CR or Morphine SR to Tapentadol ER in Subjects With Moderate to Severe Chronic Low Back or OA Pain of the Hip or Knee
Phase of Trial: Phase IV
Latest Information Update: 26 Dec 2012
At a glance
- Drugs Tapentadol (Primary)
- Indications Back pain; Osteoarthritis; Pain
- Focus Therapeutic Use
- Sponsors Janssen
- 26 Dec 2012 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.
- 07 Sep 2012 Status changed from not yet recruiting to suspended as reported by ClinicalTrials.gov.
- 07 Sep 2012 Actual initiation date (1 Aug 2012) added as reported by ClinicalTrials.gov.